RAC1 and Alzheimer disease: Prior to 2020, only two other publications had looked at the role of EMT in AD: one described triterpene celastrol as a Rac1-medicated inhibitor of EMT (114); the other described EMT markers in lens epithelial tissue from patients with AD associated subcapsular cataracts (125).